LAURA CARSTENS: Open Payments
NPI 1427488394 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 18 payments from 11 companies in 2025. Trend: 2023 $165 · 2024 $515 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $81 |
| Verity Pharmaceuticals Inc. | 2 | $54 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| Novo Nordisk Inc | 2 | $46 |
| Corcept Therapeutics | 2 | $44 |
| Medtronic, Inc. | 1 | $30 |
| Amgen Inc. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| TOLMAR, INC. | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
Products named: AIRSUPRA, Tlando, TRELEGY ELLIPTA, Korlym, VENASEAL, Ozempic, FARXIGA, REPATHA.
Industry payments across TX — which companies pay providers there.
